Intradermal acupuncture for ocular surface problems after intractable facial paralysis
Official title: The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis
Run by The First Affiliated Hospital of Zhejiang Chinese Medical University · NCT07537426 · Data updated 2026-11-12
This study will test whether tiny needles placed just under the skin can improve dry eye and other ocular surface symptoms in adults with persistent peripheral facial paralysis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 78 (estimated) |
| Sponsor | The First Affiliated Hospital of Zhejiang Chinese Medical University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | April 1, 2027 |
| Study ends | March 25, 2028 |
| Registry record updated | April 17, 2026 |
| Trial ID | NCT07537426 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 with persistent peripheral facial paralysis lasting 1 month to 1 year who report dry eye or related symptoms and have OSDI scores between 30 and 80 are the intended participants.
✕Probably not a fit
Patients with other active eye diseases (such as glaucoma or keratitis), recent intraocular surgery, lacrimal drainage obstruction, or inability to fully close the eyelid are unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional trial compares intradermal acupuncture to a sham intradermal needle in adults with intractable peripheral facial paralysis who have symptomatic ocular surface disease. The primary outcome is change in Ocular Surface Disease Index (OSDI) score, with participants receiving regular treatment sessions and follow-up assessments. Eligible participants are 18–65 years old, have facial paralysis lasting 1 month to 1 year, and present moderate-to-severe OSDI scores, while key exclusions include other active ocular disease or recent eye surgery. The protocol aims to determine whether a safe, convenient acupuncture approach can reduce symptoms and improve ocular surface health.
Why it matters
Potential benefit: If effective, intradermal acupuncture could offer a low-risk, convenient option to reduce dry eye symptoms and help protect the cornea in people with long-standing facial paralysis.
How similar studies have gone: Small acupuncture studies for dry eye have reported mixed but sometimes positive results, while intradermal acupuncture specifically for post-facial-paralysis ocular surface disease is relatively novel and not yet well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1.Male or female patients aged 18-65 years. * 2.Meets diagnostic criteria for intractable peripheral facial paralysis, with disease duration from 1 month to 1 year. FNGS 2.0 ≥15 points; ENoG shows the ratio of CMAP amplitude≤ 20%. * 3.At least one subjective ocular symptom (dryness, foreign body sensation, burning, fatigue, redness, fluctuating vision) and OSDI scores between 30 and 80. * 4.Voluntarily provides written informed consent and can comply with treatment and follow-up. Exclusion Criteria: * 1.Other ocular diseases (glaucoma, keratitis, retinopathy, acute inflammation of conjunctiva, sclera, cornea). * 2\. Intraocular surgery or laser therapy within the past 90 days. * 3.Use of systemic or topical antibiotics or tear-affecting drugs within 3 weeks; dry eye medications within 2 weeks. * 4.Lacrimal passage obstruction, dacryocystitis, punctal occlusion, or neurological impairment preventing full eyelid closure. * 5.Coagulation disorders, open wounds, or local infection at intervention sites. * 6.Allergy to press-needle materials (stainless steel, adhesive tape). * 7.Pregnancy or lactation. * 8.Severe cardiac, hepatic, renal, psychiatric disorders, or malignant tumors. * 9.Participation in another clinical trial within the past month.
Where it's running
-
The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Binyan Yu Binyan Yu
- Email: 20103034@zcmu.edu.cn
- Phone: 13758271294
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lacrifill to Help Prevent Post-Curgery Dry Eye After Cataract Surgery
This study tests Lacrifill to see if it helps prevent dry eye symptoms after unilateral cataract surgery.
-
Combined neural mobilization with proprioceptive therapy for Bell’s palsy facial symmetry
A randomized trial tests whether adding neural mobilization to proprioceptive neuromuscular facilitation helps improve facial symmetry in people with Bell’s palsy.
-
Multimodal Eye Data Bank to Explore Inflammation-Related Eye Diseases
This observational effort collects rich eye-imaging data from people with inflammatory and retinal conditions to see how the front and back of the eye relate and to build a standardized database that could support future AI tools.
-
See if rinsing the eye reduces inflammation and symptoms in severe dry eye
This trial tests whether rinsing the surface of the eye can lower inflammation and improve symptoms for people with severe dry eye disease.
-
Acoltremon 0.003% eye drops to improve tears and corneal health in Stage 1 neurotrophic keratopathy
This study will test whether Acoltremon 0.003% eye drops, used twice daily, can increase tear production and improve corneal signs in people with Stage 1 neurotrophic keratopathy who have low tear production.
-
Three-minute eyelid closure to improve corneal curvature readings
This tests whether gently closing the eyelid for three minutes before corneal measurements helps improve keratometry accuracy for adults with a 'warning' keratometry quality index who are planning cataract surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.